Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase YI Q3 2024 Earnings EPS Loss of 0145 Highlights Ongoing Operational Headwinds YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures RGTI Q1 2026 Earnings Narrower Loss Than Expected Drives Strong Stock Rally NU Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns